Vitamin D Deficiency Clinical Trials 2023

Vitamin D Deficiency Clinical Trials 2023

Vitamin D Deficiency research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in vitamin d deficiency clinical trials today.

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to vitamin d deficiency

What are the top hospitals conducting vitamin d deficiency research?

When it comes to tackling the widespread issue of vitamin d deficiency, several top hospitals are leading the way in conducting clinical trials that aim to shed light on this important health concern. The University of Texas Medical Branch in Galveston has taken a proactive approach with one ongoing trial and a total of one completed trial addressing vitamin D deficiency. This institution made its mark by initiating its first recorded study on this topic as recently as 2023.

Similarly, The University of Texas Health Science Center at Houston has also recognized the significance of investigating this nutritional deficiency. With one active trial and an overall count of one completed trial, their commitment to understanding vitamin D deficiency is evident. Their journey towards unraveling the mysteries surrounding this condition began with their inaugural study in 2022.

In Detroit, Henry Ford Health Systems and Henry Ford Health System have joined forces to combat vitamin D deficiency through rigorous research efforts. Both institutions have initiated one active clinical trial each and boast a past achievement of completing one trial pertaining specifically to vitamin D deficiency. Their contributions are particularly noteworthy given that these studies were first recorded in 2023, suggesting they are relatively new players but equally committed to making strides in addressing this pressing health issue.

Notably, even outside these specific hospitals' localized efforts, the National Institute of Environmental Health Sciences (NIEHS) located in Bethesda has dedicated itself to exploring various aspects related not only environmental concerns but also public health issues such as Vitamin-D deficiencies where they too engage into comprehending & assessing vital dynamics involved through employing similar approaches; hence being an equal contributor alongside aforementioned facilities within same year2019 marking beginning phase for their focused analysation. Collectively, these medical institutions demonstrate our increasing recognition regarding the importance and impact that adequate levels of Vitamin D can have on overall well-being - whether it be preventing chronic diseases or supporting optimal bone health- all contributing together towards ensuring brighter prospects for individuals grappling with Vitamin-D insufficiencies worldwide

Which are the best cities for vitamin d deficiency clinical trials?

When it comes to clinical trials focused on vitamin d deficiency, several cities have emerged as leaders in research. Boston, Massachusetts takes the lead with 3 active trials exploring treatments such as UVB treatment and high Vitamin D3 supplementation. Following closely behind are Detroit, Michigan and Bethesda, Maryland, each with 2 ongoing studies investigating the effects of Vitamin D. Ventura, California also boasts 2 active trials focused on a specific group receiving Vitamin D3 supplementation. Lastly, Galveston, Texas features 1 trial examining usual care combined with vitamin D supplementation. These cities offer valuable opportunities for individuals interested in participating in clinical trials related to vitamin D deficiency and its potential treatments.

Which are the top treatments for vitamin d deficiency being explored in clinical trials?

Clinical trials are paving the way for advancements in treating vitamin d deficiency. Leading the charge is vitamin D itself, with three ongoing trials and an impressive 92 all-time trials dedicated to combating this deficiency since its first listing in 2001. Cholecalciferol also holds promise, currently being explored in two active clinical trials and boasting a total of 62 all-time studies focused on addressing vitamin D deficiency since it was introduced back in 2005. Additionally, a novel approach involving 800 IU/day vitamin D supplementation with feedings during the first 28 days after birth has entered the scene, showing potential through one ongoing trial and two total trials since its recent debut in 2022. These innovative treatments offer hope for individuals grappling with vitamin D deficiency worldwide.

What are the most recent clinical trials for vitamin d deficiency?

Recent clinical trials have shed light on potential breakthroughs in the treatment of vitamin d deficiency. One promising study is exploring the use of vitamin D supplementation to address this widespread issue. Additionally, researchers are investigating the effectiveness of CTAP101 capsules in two separate cohorts to evaluate its impact on alleviating vitamin D deficiency. Another trial focuses on ergocalciferol capsules and their role in combating this condition. Furthermore, a study has examined the benefits of neoadjuvant chemotherapy as a standard care approach for individuals with vitamin D deficiency. These comprehensive investigations offer hope for improved interventions and management strategies for those affected by this prevalent health concern

What vitamin d deficiency clinical trials were recently completed?

A recent clinical trial addressing vitamin d deficiency has concluded, shedding light on potential strategies to combat this health issue. Sponsored by Louisiana State University Health Sciences Center Shreveport, the trial focused on the effectiveness of Vitamin D supplementation. Completed in November 2020, its results provide valuable insights into the role of Vitamin D in managing and preventing deficiencies. This research represents a significant step forward in understanding how best to address this common nutritional concern and its associated health implications.